Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/50253
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSurasak Saokaewen_US
dc.contributor.authorWimon Suwankesawongen_US
dc.contributor.authorUnchalee Permsuwanen_US
dc.contributor.authorNathorn Chaiyakunapruken_US
dc.date.accessioned2018-09-04T04:27:17Z-
dc.date.available2018-09-04T04:27:17Z-
dc.date.issued2011-03-23en_US
dc.identifier.issn11791942en_US
dc.identifier.issn01145916en_US
dc.identifier.other2-s2.0-79952755021en_US
dc.identifier.other10.2165/11586590-000000000-00000en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79952755021&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/50253-
dc.description.abstractBackground: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. Objectives: The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Methods: Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. © 2011 Adis Data Information BV. All rights reserved.en_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleSafety of herbal products in Thailand: An analysis of reports in the thai health product vigilance center database from 2000 to 2008en_US
dc.typeJournalen_US
article.title.sourcetitleDrug Safetyen_US
article.volume34en_US
article.stream.affiliationsUniversity of Phayaoen_US
article.stream.affiliationsThailand Ministry of Public Healthen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsNaresuan Universityen_US
article.stream.affiliationsUniversity of Queenslanden_US
article.stream.affiliationsUniversity of Wisconsin Madisonen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.